What conferences did you miss in February? Review them here.

In the last month, MDLinx editors covered a number of interesting and cutting edge conferences, including those on retroviruses and opportunistic infections, critical care medicine, pain medicine, multiple sclerosis, rheumatology, and stroke. Highlights of some of these conferences are described here. As reported at the 23rd Conference on Retroviruses and Opportunistic Infections, which was held in Boston, MA, February 22-25, between 2004 and 2010, the percentage of HIV-positive patients who were screened for Neisseria (NG) and Chlamydia (CT) increased from 22% to 39%. “As NG/CT testing increased, the test positivity also increased, yielding an overall improvement in case detection in […]

Abuse of Opioids and Heroin Reaching Epidemic Levels

With the United States Senate passing of the bipartisan Stopping Medication Abuse and Protecting Seniors Act (See Washington Report, March 3, 2016), which is designed to cut down on inappropriate access to opioids, improve patient care for at–risk beneficiaries, and save taxpayers money, it is more than clear that abuse of opioids and heroin has become a serious problem in the US.   A recent report, published March 1, 2016 on the American Association for Clinical Chemistry website, discusses the dramatic increase in heroin and painkiller use in the Cincinnati, Ohio area prompting a neonatologist at Cincinnati Children’s Perinatal Institute […]

See What You Missed at January Medical Conferences

In the last month, MDLinx editors covered a number of interesting and cutting edge conferences, including gastrointestinal cancer, cancer survivorship, and genitourinary cancer. Here are a few of the highlights from those conferences. The 2016 Gastrointestinal Cancer Symposium was held in San Francisco, CA January 21-23, 2016. According to one study, during the past 10 years in the United States, the use of neoadjuvant chemoradiation therapy (NACRT) before surgery in patients with locally advanced rectal cancer has substantially increased, but only 50% of these patients currently receive standard therapy as recommended by national guidelines. Moreover, tri-modality therapy was associated with […]